Skip to main content

BNP PARIBAS ARBITRAGE, SA

Position in BTAI — BioXcel Therapeutics, Inc.

CIK 1166588 NEW YORK, NY

Position in BTAI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$16
-$63 QoQ
Shares Held
12
-79.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 47 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in BTAI Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $502,986,525 across 54 Drug Manufacturers - Specialty & Generic names. BTAI ranks #53 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BTAI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16 12
2026-03-31 $79 59
2025-12-31 $19 12
2025-09-30 $99 39
2025-06-30 $79 44
2025-03-31 $89 44
2024-12-31 $868 2,321
2024-09-30 $27,072 44,381
2024-06-30 $349,612 273,135
2024-03-31 $61,335 21,750
2023-12-31 $69,100 23,424
2023-09-30 $192,920 76,253
2023-06-30 $466,160 69,994
2023-03-31 $2,122,948 113,770
2022-12-31 $759,812 35,373
2022-09-30 $637,937 53,971
2022-06-30 $830,979 62,953
2022-03-31 $1,741,698 83,295
2021-12-31 $1,358,735 66,834
2021-09-30 $767,035 25,273
2021-06-30 $518,691 17,849
2021-03-31 $386,497 8,955
2020-12-31 $64,449 1,395
2020-09-30 $131,250 3,027
2020-06-30 $117,629 2,219
2020-03-31 $46,689 2,089